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A 73-year-old womanwas admitted and treated because of epigastric fullness, palpitation, and tarry stool
for 2 days. Gastric cancer was found via panendoscopy. A preoperative abdominal computed tomo-
graphic scan revealed a hypervascular mass in the left kidney; renal cell carcinoma (RCC) was the initial
impression. A concomitant surgery for subtotal gastrectomy and radical left nephrectomy was per-
formed. The pathological examination conﬁrmed gastric adenocarcinoma (T2a) and RCC (T2b). Conva-
lescence was uneventful and she was discharged in stable condition. There was no evidence of tumor
recurrence at a 20-month follow-up examination. Elderly people with early gastric cancers have a rela-
tive higher probability of developing a synchronous tumor than younger people. The incidence of
synchronous gastric cancer and RCC is quite low, and concomitant surgery is rare. Surgeons need to be
aware of the possibility of a synchronous second primary cancer when the initial gastric cancer is
diagnosed. A concomitant surgery for gastrectomy and radical nephrectomy can be safely performed in
selected patients, which can achieve feasible oncological control.
Copyright  2012, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Synchronous presentations of cancer in patients with gastric
cancer are infrequent. The incidence of synchronous renal cell
carcinoma (RCC) with gastric cancer is quite low (0.11e0.37%), and
concomitant surgery for treating gastric cancer and RCC is rare.
Because patients with gastric cancer are at risk of developing
a second, additional primary form of cancer, this may negatively
inﬂuence the clinical prognosis.1,2 Surgeons should try to diagnose
synchronous cancers in gastric cancer patients, especially in the
elderly.3 Herein, we present our experience of performing
a concomitant gastrectomy and nephrectomy on a patient diag-
nosed with synchronous gastric cancer and RCC.2. Case report
A 73-year-old woman was admitted to our hospital because of
epigastric fullness, heart palpitations, and tarry stool passage for 2
days. She was a vegetarian and nonsmoker. She denied progressive
body weight loss in recent months. A physical examinationi Medical Center, 901 Chung-
eng).
ciation. Published by Elsevier Taiwdemonstrated no palpable abdominal masses or tenderness;
however, pale conjunctiva was found. Blood tests exhibited low
hemoglobin (5.1 g/dL), and a blood transfusion was given. Stool
occult blood test resultswerepositive, and apanendoscopy revealed
a large ulcer with an elevated margin located at the great curvature
of the stomach, indicatingBowman type II or III lesions. A biopsywas
performed, and the pathology report indicated gastric adenocarci-
noma. Abdominal computed tomography (CT) revealed a hyper-
vascular tumor in the left kidneymeasuring 12912 cm (Fig.1). A
primary or metastatic renal tumor was the initial impression. A
concomitant subtotal gastrectomy (Fig. 2) and radical left nephrec-
tomy (Fig. 3) were performed. The total operative time was 395
minutes, and the estimated blood loss was 750 mL. Paralytic ileus
was found postoperatively, and conservative treatment was
administered to this patient. She was discharged on the 16th day
after surgery. The ﬁnal pathology report indicated a moderately
differentiatedgastric adenocarcinoma (pT2aN0M0;Fig. 2) andclear-
and granular-type RCC (pT2N0M0; Fig. 3). Therewas no evidence of
recurrence after at the 20-month follow-up examination.
3. Discussion
The incidence of gastric cancer with a second, synchronously
presenting primary cancer varies from 2.0e10.9%. Colorectal,an LLC. Open access under CC BY-NC-ND license.
Fig. 1. A demarcated hypervascular tumor in the left kidney measuring approximately
12  9  12 cm.
Fig. 2. A Bormann type II lesion (arrow) measuring approximately 3  3 cm, which
was found during the subtotal gastrectomy. The pathological report conﬁrmed
a moderately differentiated adenocarcinoma that had invaded the muscularis propria
layer (hematoxylin & eosin, 200).
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literature. However, synchronous RCC is rare. The incidence
ranges from 0.11e0.37%, and the male-to-female ratio is 2:1.1e4
Although studying different populations and using different
methods may have contributed to differences in the reported
rates of incidence, it has been reported that the incidence of
synchronous cancer is higher in early-stage gastric cancers than
in the advanced stages of the disease (5.2% vs. 2.4%, p < 0.001) in
a retrospective study.3 This might be associated with the
increasing incidence of early gastric cancer and the fact that
patients who are diagnosed with colorectal cancer routinely
undergo gastroscopies.
Gastrointestinal symptoms are the most common clinical
manifestations in patients with synchronous cancer of the kidney
and stomach.5 Most renal tumors are found incidentally via
imaging studies. Although the left renal tumor mass was large
enough to palpate in our patient, the patient presented with no
complaints regarding the classical triad of RCC (hematuria, groin
pain, and the presence of a palpable mass).
There are few reports that discuss the preferred treatment
modality for improving the clinical prognosis of patients with
synchronous gastric cancer and RCC. The pathological stage of the
secondary primary cancer might be the primary factor that inﬂu-
ences the treatment modality for these patients. Most patients who
have resectable synchronous tumors have both tumors operated onat the same time, and this does not lead to increased postoperative
mortality.6 Althoughminor complications (e.g., ileus and prolonged
hospitalization) do occur, there are typically no major complica-
tions during hospitalization.
The survival rate is 84.1% at 3 years and 69.3% at 5 years for
patients with a second primary cancer. The respective 10-year
survival rates are 69.3% and 40.1% for gastric cancer patients
without and with a second primary cancer. This difference
between the two groups is statistically signiﬁcant.1 Ha et al found
that the 5-year survival rate was only 24% after therapeutic
resection was performed on 11 patients who had been simulta-
neously diagnosed with gastric cancer and RCC.4 In our patient, no
tumor recurrence was noted on at 20-month follow-up exami-
nation, although more time is required to further elucidate these
results.
It has been reported that an unstable genetic status, micro-
satellite instability, family history, and environmental factors (e.g.,
diet, smoking, etc.) are risk factors for the development of second
Fig. 3. A 13  12-cm, straw-colored, elastic tumor (arrow) in the left kidney. The path-
ological report conﬁrmed that the tumor was a renal cell carcinoma, with both clear and
granular cell types, that was limited to the kidney. (hematoxylin & eosin, 200).
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Cheng et al.’s suggestion that radiotherapy and/or chemotherapy
may play an important role in the oncogenicity of multiple primarycancers as the molecular basis for the association of synchronous
double cancers is not completely understood.8 Negative TP53 and
RASmutations have been reported in patients with alimentary tract
malignancies.9 However, there are still no studies describing the
genetic events that lead to the development of synchronous gastric
adenocarcinoma and RCC.
More than 50% of metachronous tumors that appear after early
gastric cancer are diagnosed within 5 years after surgery.7 It is
important to detect synchronous or metachronous carcinomas at
sites other than the stomach in patients with early gastric cancer
during the course of long-term follow-up examinations. We
suggest that postoperative examinations be periodically performed
for at least 5 years after surgery.
Finally, synchronous gastric cancer and RCC are rare, and radical
surgery plays a major role in treatment. It is believed that
a concomitant gastrectomy and radical nephrectomy can be safely
performed in selected patients without the development of major
complications. Feasible oncologic control and a survival should be
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